Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

详细信息    查看全文

• 作者：Alexander A. Leung ; MD ; MPH^a ; ^{aacleung@ucalgary.ca" class="auth_mail" title="E-mail the corresponding author} ; Kara Nerenberg ; MD ; MSc^b ; Stella S. Daskalopoulou ; MD ; PhD^c ; Kerry McBrien ; MD ; MPH^d ; Kelly B. Zarnke ; MD ; MSc^e ; Kaberi Dasgupta ; MD ; MSc^c ; Lyne Cloutier ; RN ; PhD^f ; Mark Gelfer ; MD^g ; Maxime Lamarre-Cliche ; MD^h ; Alain Milot ; MD ; MSc ; MDⁱ ; Peter Bolli ; MD^j ; Guy Tremblay ; MD^k ; Donna McLean ; RN ; NP ; PhD^l ; Sheldon W. Tobe ; MD ; MSc(HPTE)^m ; Marcel Ruzicka ; MD ; PhDⁿ ; Kevin D. Burns ; MDⁿ ; Michel Vallé ; e ; MD ; PhD^o ; G.V. Ramesh Prasad ; MBBS ; MSc^m ; Marcel Lebel ; MDⁱ ; Ross D. Feldman ; MD^p ; Peter Selby ; MBBS ; MHSc^q ; Andrew Pipe ; CM ; MD^r ; Ernesto L. Schiffrin ; MD ; PhD^s ; Philip A. McFarlane ; MD ; PhD^t ; Paul Oh ; MD^u ; Robert A. Hegele ; MD^v ; Milan Khara ; MBChB^w ; Thomas W. Wilson ; MD^x ; S. Brian Penner ; MD^y ; Ellen Burgess ; MD^z ; Robert J. Herman ; MD^e ; Simon L. Bacon ; PhD^aa ; Simon W. Rabkin ; MD^bb ; Richard E. Gilbert ; MD ; PhD^cc ; Tavis S. Campbell ; PhD^dd ; Steven Grover ; MD ; MPA^ee ; George Honos ; MD^ff ; Patrice Lindsay ; RN ; PhD^gg ; Michael D. Hill ; MD ; MSc^hh ; Shelagh B. Coutts ; MDⁱⁱ ; Gord Gubitz ; MD^jj ; Norman R.C. Campbell ; MD^kk ; Gordon W. Moe ; MD ; MSc^ll ; Jonathan G. Howlett ; MD^mm ; Jean-Martin Boulanger ; MDⁿⁿ ; Ally Prebtani ; MD^oo ; Pierre Larochelle ; MD^h ; Lawrence A. Leiter ; MD^pp ; Charlotte Jones ; MD ; PhD^qq ; Richard I. Ogilvie ; MD^rr
• 刊名：Canadian Journal of Cardiology
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：32
• 期：5
• 页码：569-588
• 全文大小：947 K

文摘

Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 new recommendations, as well as revisions to 2 previous recommendations. In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure. Also, although a serum lipid panel remains part of the routine laboratory testing for patients with hypertension, fasting and nonfasting collections are now considered acceptable. For individuals with secondary hypertension arising from primary hyperaldosteronism, adrenal vein sampling is recommended for those who are candidates for potential adrenalectomy. With respect to the treatment of hypertension, a new recommendation that has been added is for increasing dietary potassium to reduce blood pressure in those who are not at high risk for hyperkalemia. Furthermore, in selected high-risk patients, intensive blood pressure reduction to a target systolic blood pressure ≤ 120 mm Hg should be considered to decrease the risk of cardiovascular events. Finally, in hypertensive individuals with uncomplicated, stable angina pectoris, either a β-blocker or calcium channel blocker may be considered for initial therapy. The specific evidence and rationale underlying each of these recommendations are discussed. Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force will continue to provide annual updates.